Continuing Medical Education
Expert Guidance on Frequently Asked Questions Regarding the Use of ADCs in TNBC
Expiration Date: 2026-08-15
Evaluating the Latest Data and Ongoing Trials for Novel ADC Approaches in TNBC
Expiration Date: 2026-08-15
Establishing the Rationale for ADC and ICI Combinations in TNBC
Expiration Date: 2026-08-15
Breaking Down the Rationale for Targeting TROP2 in TNBC
Expiration Date: 2026-08-15
Dissecting Clinical Trial and Real-World Data for ADCs in TNBC
Expiration Date: 2026-08-15
Breast Cancer Tumor Board: Targeting TROP2 – Innovations in Triple-Negative Breast Cancer Treatment
Expiration Date: 2026-07-31
Oncology Town Hall™ 2025 ESMO-GI Congress Highlights: The Latest Data on Immune-Based Strategies Across Hepatobiliary Cancers
Expiration Date: 2025-09-15
GI Tumor Board—Applying Recent Advances in Biomarker Testing and Treatment in Metastatic Colorectal Cancer
Expiration Date: 2026-07-11
Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing
Expiration Date: 2026-07-11
Medical Crossfire®: Precision Medicine in Glioma Treatment — Integration of Molecular Profiling to Inform Targeted Therapies
Expiration Date: 2026-07-11
Cases and Conversations™: Sorting Through the Expanding Treatment Options for Patients with Relapsed/Refractory Multiple Myeloma
Expiration Date: 2026-07-11
PER Tumor Board®: Applying Recent Advances to Transform the Treatment Paradigm in SCLC—Expert Perspectives on New Approvals and Emerging Strategies
Expiration Date: 2026-07-11
Medical Crossfire®: Harnessing the Power of Modern Therapies in Newly Diagnosed Multiple Myeloma
Expiration Date: 2026-07-11
Medical Crossfire®: Improving Patient Outcomes in Myeloproliferative Neoplasms With Novel Therapeutic Approaches
Expiration Date: 2026-07-11
Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC
Expiration Date: 2026-07-11
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
Expiration Date: 2026-07-11
Cases & Conversations™: Transforming AML Care—Precision Strategies, Evolving Therapies, and Clinical Insights
Expiration Date: 2026-07-11
Medical Crossfire®: Integrating Next-Generation Endocrine Targeting Therapies to Improve Outcomes for Patients With HR+/HER2- Breast Cancer
Expiration Date: 2026-07-11
A Case-Guided Discussion on Managing Immune Thrombocytopenic Purpura (ITP)
Expiration Date: 2026-06-30
Community Practice Connections™: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma
Expiration Date: 2026-05-15
Proactive Adverse Event Management for HER2+ BTC Treatments
Expiration Date: 2026-05-08
